{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:12Z","timestamp":1772121672152,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.thromres.2023.05.002","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T20:51:45Z","timestamp":1683147105000},"page":"40-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cross-sectional analysis of open payments for physicians at designated hemophilia centers in the US (2018\u20132020)"],"prefix":"10.1016","volume":"227","author":[{"given":"Alyson","family":"Haslam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2023.05.002_bb0010","first-page":"316","article-title":"Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis","volume":"27","author":"Croteau","year":"2021","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"6 Suppl","key":"10.1016\/j.thromres.2023.05.002_bb0015","first-page":"S123","article-title":"Hemophilia in the managed care setting","volume":"21","author":"Dalton","year":"2015","journal-title":"Am. J. Manag. Care"},{"issue":"3","key":"10.1016\/j.thromres.2023.05.002_bb0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaoncol.2020.6591","article-title":"Trends in industry payments to medical oncologists in the United States since the inception of the open payments program, 2014 to 2019","volume":"7","author":"Tarras","year":"2020","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2023.05.002_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/M20-5665","article-title":"Are financial payments from the pharmaceutical industry associated with physician prescribing? : a systematic review","volume":"174","author":"Mitchell","year":"2021","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2023.05.002_bb0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12913-018-3043-8","article-title":"Association between industry payments and prescribing costly medications: an observational study using open payments and Medicare part D data","volume":"18","author":"Sharma","year":"2018","journal-title":"BMC Health Serv. Res."},{"issue":"5","key":"10.1016\/j.thromres.2023.05.002_bb0035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1634\/theoncologist.2018-0423","article-title":"Evaluating the strength of the association between industry payments and prescribing practices in oncology","volume":"24","author":"Mitchell","year":"2019","journal-title":"Oncologist"},{"issue":"17","key":"10.1016\/j.thromres.2023.05.002_bb0040","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/jama.2020.11413","article-title":"Trends in industry payments to physicians in the United States from 2014 to 2018","volume":"324","author":"Marshall","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.thromres.2023.05.002_bb0045","first-page":"781","article-title":"Industry payments in cardiology: a cross-sectional analysis of open payments data","volume":"118","author":"Jaiswal","year":"2018","journal-title":"J. Am. Osteopath. Assoc."},{"issue":"5","key":"10.1016\/j.thromres.2023.05.002_bb0050","article-title":"Review of industry payments to general orthopaedic surgeons reported by the open payments database: 2014 to 2019","volume":"5","author":"Braithwaite","year":"2021","journal-title":"J. Am. Acad. Orthop. Surg. Glob. Res. Rev"},{"issue":"4","key":"10.1016\/j.thromres.2023.05.002_bb0055","doi-asserted-by":"crossref","DOI":"10.5070\/D3244039372","article-title":"Industry payments to dermatologists: updates from the 2016 open payment data","volume":"24","author":"Schlager","year":"2018","journal-title":"Dermatol. Online J."},{"issue":"4","key":"10.1016\/j.thromres.2023.05.002_bb0065","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/hae.13758","article-title":"Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia","volume":"25","author":"Croteau","year":"2019","journal-title":"Haemophilia"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:50:27Z","timestamp":1758736227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":11,"alternative-id":["S0049384823001287"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.05.002","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.03.07.23286934","asserted-by":"object"}]},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-sectional analysis of open payments for physicians at designated hemophilia centers in the US (2018\u20132020)","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}